Light-Based Imaging of Green Fluorescent Protein-Positive Ovarian Cancer Xenografts during Therapy
- 30 September 2001
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 82 (3) , 581-589
- https://doi.org/10.1006/gyno.2001.6297
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Staging of Advanced Ovarian Cancer: Comparison of Imaging Modalities—Report from the Radiological Diagnostic Oncology GroupRadiology, 2000
- Classification of Asymptomatic Adnexal Masses by Ultrasound, Magnetic Resonance Imaging, and Positron Emission TomographyGynecologic Oncology, 2000
- Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinomaEuropean Radiology, 2000
- 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDGPublished by Elsevier ,2000
- Whole-body optical imaging of green fluorescent protein-expressing tumors and metastasesProceedings of the National Academy of Sciences, 2000
- Three-Dimensional Ultrasound and Power Doppler Improve the Diagnosis of Ovarian LesionsGynecologic Oncology, 2000
- Status of Scintimammography and its Relationship to other Detection Methods for Breast CancerCancer Biotherapy & Radiopharmaceuticals, 1999
- Epithelial ovarian cancer: prevention, diagnosis, and treatmentCA: A Cancer Journal for Clinicians, 1999
- Diagnostic efficacy of the preoperative lymphoscintigraphy, Ga-67 scintigraphy and computed tomography for detection of lymph node metastasis in cases with ovarian or endometrial carcinomaActa Obstetricia et Gynecologica Scandinavica, 1999
- Screening for Ovarian CancerCancer Control, 1996